Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Operating activities
Net income	$ 26,725	$ 18,310
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	9,818	8,712
Amortization of discounts, fees and deferred financing costs	853	1,174
Stock-based compensation	443	3,162
Accrued interest on debt agreements	8,310	4,607
Non-cash rent charges	447	178
Change in operating assets and liabilities, net of acquisitions:
Accounts receivable	1,584	(4,990)
Inventories	94	(2,876)
Prepaid expenses and other current assets	(2,021)	173
Other assets	(811)	(648)
Accounts payable	1,290	(1,493)
Accrued compensation and benefits	622	2,285
Accrued expenses and other current liabilities	(6,695)	(4,505)
Other liabilities	4,574	2,574
Cash provided by operating activities	45,233	26,663
Investing activities
Purchases of property and equipment	(14,483)	(8,827)
Cash paid for acquisitions	(6,519)	(1,409)
Cash paid for predecessor entity, net of cash acquired		(2,182)
Cash used in investing activities	(21,002)	(12,418)
Financing activities
Proceeds from term loans	4,028
Payments on long-term debt	(1,444)	(1,556)
Payments on capital lease obligations	(25)	(24)
Proceeds from issuance of common stock	436	6
Distributions to noncontrolling interests	(20,860)	(16,024)
Issuance of debt		135,600
Debt issuance costs		(3,375)
Return of capital dividend		(130,720)
Contributions from noncontrolling interests	2,911	686
Purchases of noncontrolling interests	(905)	(857)
Proceeds from sales of additional noncontrolling interests	170	545
Cash used in financing activities	(15,689)	(15,719)
Increase (decrease) in cash and cash equivalents	8,542	(1,474)
Cash and cash equivalents at beginning of period	36,774	21,179
Cash and cash equivalents at end of period	45,316	19,705
Supplemental Disclosure of Cash Flow Information
Cash paid for income taxes	1,455	478
Cash paid for interest	11,794	10,905
Supplemental Disclosure of Non-Cash Financing Activities
Issuance of notes in exchange for interest payments	7,453
Amount payable for acquisition	14,700
Conversion of line of credit to term loan	$ 1,004

American Renal Associates Holdings, Inc. 10-Q